These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22426498)

  • 61. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
    Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.
    Pfeilschifter J; Cooper C; Watts NB; Flahive J; Saag KG; Adachi JD; Boonen S; Chapurlat R; Compston JE; Díez-Pérez A; LaCroix AZ; Netelenbos JC; Rossini M; Roux C; Sambrook PN; Silverman S; Siris ES
    Osteoporos Int; 2012 Aug; 23(8):2179-88. PubMed ID: 22086311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Su Y; Leung J; Hans D; Lamy O; Kwok T
    Osteoporos Int; 2017 Jan; 28(1):111-117. PubMed ID: 27565645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Holloway KL; Mohebbi M; Betson AG; Hans D; Hyde NK; Brennan-Olsen SL; Kotowicz MA; Pasco JA
    Osteoporos Int; 2018 Jan; 29(1):101-108. PubMed ID: 28940052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
    Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
    Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictive value of FRAX for fracture in obese older women.
    Premaor M; Parker RA; Cummings S; Ensrud K; Cauley JA; Lui LY; Hillier T; Compston J;
    J Bone Miner Res; 2013 Jan; 28(1):188-95. PubMed ID: 22890977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies.
    Cappelle SI; Ramon I; Dekelver C; Rozenberg S; Baleanu F; Karmali R; Rubinstein M; Tondeur M; Moreau M; Paesmans M; Bergmann P; Body JJ
    Maturitas; 2017 Dec; 106():1-7. PubMed ID: 29150162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
    Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
    Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
    Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
    Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.
    McCloskey E; Johansson H; Harvey NC; Shepstone L; Lenaghan E; Fordham R; Harvey I; Howe A; Cooper C; Clarke S; Gittoes N; Heawood A; Holland R; Marshall T; O'Neill TW; Peters TJ; Redmond N; Torgerson D; Kanis JA;
    J Bone Miner Res; 2018 Jun; 33(6):1020-1026. PubMed ID: 29480960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
    Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
    BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Accuracy of FRAX
    Bisson EJ; Finlayson ML; Ekuma O; Marrie RA; Leslie WD
    J Bone Miner Res; 2019 Jun; 34(6):1095-1100. PubMed ID: 30690793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
    Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
    Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Five-year fracture risk estimation in patients with Parkinson's disease.
    Pouwels S; Bazelier MT; de Boer A; Weber WE; Neef CK; Cooper C; de Vries F
    Bone; 2013 Oct; 56(2):266-70. PubMed ID: 23800516
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of FRAX to characterise fracture risk in Poland.
    Czerwinski E; Kanis JA; Osieleniec J; Kumorek A; Milert A; Johansson H; McCloskey EV; Gorkiewicz M
    Osteoporos Int; 2011 Sep; 22(9):2507-12. PubMed ID: 21127840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.
    Cheung E; Cheung CL; Kung AW; Tan KC
    Osteoporos Int; 2014 Mar; 25(3):1017-23. PubMed ID: 24196720
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
    Guggina P; Flahive J; Hooven FH; Watts NB; Siris ES; Silverman S; Roux C; Pfeilschifter J; Greenspan SL; Díez-Pérez A; Cooper C; Compston JE; Chapurlat R; Boonen S; Adachi JD; Anderson FA; Gehlbach S;
    Bone; 2012 Dec; 51(6):975-80. PubMed ID: 22964142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.